WA People
BILL · 2017–18 SESSION · LATEST VERSION SSB 5035

SB 5035: Investigational med. product

Concerning patients' access to investigational medical products.

Summary

  • Permits patients who are suffering from a serious or immediately life-threatening disease to use investigational medical products that have been partially tested by the Food and Drug Administration (FDA), but are not available for patient use.
  • Provides that the patient's health insurance provider is not required to provide coverage for the investigational medical product or harm caused to the patient as a result of product use.

From the Substitute Senate Bill Report (SSB 5035), written by the Legislature's nonpartisan staff. Read the full report ↗

Enacted Enacted · Chapter 212, Laws of 2017
  1. IntroducedJan 11, 2017
  2. Out of committeeFeb 3, 2017
  3. Passed SenateFeb 28, 2017
  4. Passed HouseApr 6, 2017
  5. GovernorMay 5, 2017
  6. LawMay 5, 2017
Prime sponsor
Jamie Pedersen (D-43)
Introduced
January 11, 2017 in the Senate
Last action
May 5, 2017
Session law
Chapter 212, Laws of 2017
Budget
Has a fiscal note
Versions
SB 5035, SSB 5035

AN ACT Relating to patients' access to investigational medical products;

Sponsors

Prime sponsor: Jamie Pedersen (D-43)

12 co-sponsors (7 Democrats, 5 Republicans)

Senator R-18Annette Cleveland D-49Senator R-2Karen Keiser D-33Maureen Walsh R-16Steve Conway D-29Barbara Bailey R-10Steve O'Ban R-28Mark Mullet D-5Patty Kuderer D-48Jeannie Darneille D-27Lisa Wellman D-41

Votes

Senate · 3rd Reading & Final Passage

Passed February 28, 2017
Version voted on: SSB 5035
49 Yea 0 Nay 0 Absent 0 Excused
PartyYeaNayAbsentExcused
Democrat25000
Republican24000
How each member voted
Permalink to this vote

House · Final Passage as Amended by the House

Passed April 6, 2017
Version voted on: SSB 5035
97 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat50000
Republican47001
How each member voted

Yea (97)

Excused (1)

Permalink to this vote

Senate · Final Passage as Amended by the House

Passed April 17, 2017
Version voted on: SSB 5035
48 Yea 0 Nay 0 Absent 1 Excused
PartyYeaNayAbsentExcused
Democrat24001
Republican24000
How each member voted

Excused (1)

Permalink to this vote

History

  1. Effective date 7/23/2017. (SSB 5035)
  2. Chapter 212, 2017 Laws. (SSB 5035)
  3. Governor signed. (SSB 5035)
  4. Delivered to Governor. (SSB 5035)
  5. Speaker signed. (SSB 5035)
  6. President signed. (SSB 5035)
  7. Passed final passage; yeas, 48; nays, 0; absent, 0; excused, 1. (SSB 5035)
  8. Senate concurred in House amendments. (SSB 5035)
  9. Third reading, passed; yeas, 97; nays, 0; absent, 0; excused, 1. (SSB 5035)
  10. Rules suspended. Placed on Third Reading. (SSB 5035)
  11. Floor amendment(s) adopted. (SSB 5035)
  12. Committee amendment not adopted. (SSB 5035)
  13. Placed on second reading by Rules Committee. (SSB 5035)
  14. Referred to Rules 2 Review. (SSB 5035)
  15. Committee relieved of further consideration. (SSB 5035)
  16. Referred to Appropriations. (SSB 5035)
  17. HCW - Majority; do pass with amendment(s). (SSB 5035)
  18. First reading, referred to Health Care & Wellness (Not Officially read and referred until adoption of Introduction report). (SSB 5035)
  19. Rules suspended. Placed on Third Reading. (SSB 5035)
  20. Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0. (SSB 5035)
  21. 1st substitute bill substituted. (SSB 5035)
  22. 1st substitute bill substituted.
  23. Placed on second reading by Rules Committee. (SSB 5035)
  24. Placed on second reading by Rules Committee.
  25. Passed to Rules Committee for second reading. (SSB 5035)
  26. Passed to Rules Committee for second reading.
  27. HLTH - Majority; 1st substitute bill be substituted, do pass. (SSB 5035)
  28. Minority; without recommendation. (SSB 5035)
  29. Minority; without recommendation.
  30. HLTH - Majority; 1st substitute bill be substituted, do pass.
  31. First reading, referred to Health Care.

SB 5035 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page